Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 8th, 2023%
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds
By Alan, on October 10th, 2023%
A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs. . . . → Read More: FDA Funds Study of Real World Data for Biosimilars
By Alan, on October 6th, 2023%
A biotechnology company is receiving NIH support for discovering antibodies that address the vast majority of proteins coded by the human genome, passed-up so far by drug makers. . . . → Read More: NIH Funds Antibody Discovery for Difficult Protein Targets
By Alan, on October 5th, 2023%
Research with lab mice shows an experimental vaccine stimulates the body’s basic immune system to protect against a range of pathogens associated with hospital infections. . . . → Read More: Vaccine Shown to Protect Against Multiple Hospital Pathogens
By Alan, on October 3rd, 2023%
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies
By Alan, on September 21st, 2023%
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy. . . . → Read More: Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
By Alan, on September 13th, 2023%
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment
By Alan, on September 9th, 2023%
The number of new infections from the human immunodeficiency virus or HIV declined worldwide last year and over the past decade, with the sharpest declines in sub-Saharan Africa. . . . → Read More: Infographic – HIV Infections Fall in Africa. Rise in Mideast, Europe
By Alan, on August 24th, 2023%
A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device. . . . → Read More: Grant Funds Typhoid Vaccine Patch Development
By Alan, on August 22nd, 2023%
A company creating a digital process to monitor farm insect pests is receiving funds to expand its technology for tracking and counting mosquitoes as a general public health threat. . . . → Read More: Small Biz Award Funds A.I. Mosquito Monitoring System
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|